000 | 01236 a2200301 4500 | ||
---|---|---|---|
005 | 20250517063910.0 | ||
264 | 0 | _c20161007 | |
008 | 201610s 0 0 eng d | ||
022 | _a1751-2441 | ||
024 | 7 |
_a10.1586/17512433.2016.1123616 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSingh, Awadhesh Kumar | |
245 | 0 | 0 |
_aCombination therapy of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: rationale and evidences. _h[electronic resource] |
260 |
_bExpert review of clinical pharmacology _c2016 |
||
300 |
_a229-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aGlucose _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
650 | 0 | 4 | _aSodium-Glucose Transporter 2 Inhibitors |
700 | 1 | _aSingh, Ritu | |
773 | 0 |
_tExpert review of clinical pharmacology _gvol. 9 _gno. 2 _gp. 229-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1586/17512433.2016.1123616 _zAvailable from publisher's website |
999 |
_c25468372 _d25468372 |